Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review

BACKGROUND: Data suggests that males experience less toxicity and poorer survival than females treated for Ewing’s sarcoma. We instituted an intra-patient dose escalation (DE) policy with Vincristine/Doxorubicin/Cyclophosphamide (VDC) alternating with Ifosfamide/Etoposide (IE) based on hematological...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lewin, Jeremy, Wieringa, Samantha, Collins, Marnie, Desai, Jayesh, Orme, Lisa, Lingaratnam, Senthil, Thomas, David M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3866566/
https://ncbi.nlm.nih.gov/pubmed/24321600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-3329-3-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados